ArticleThe Psychiatric quarterly2025
Why are we still using the PHQ-9? A Historical Review and Psychometric Evaluation of Measurement Invariance.
Article in The Psychiatric quarterly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Linking childhood adversity with borderline and depressive symptoms: the role of reward processing.European journal of psychotraumatology · 2026Article
- Anna vs. Judith: A randomized comparison of AI-delivered psychodynamic and cognitive behavioral therapies for social anxiety disorder.Internet interventions · 2026Article
- Ethnocultural differences in symptom change, engagement, and adherence in internet-delivered cognitive behavioral therapy: A secondary analysis of a healthcare-embedded longitudinal study.Internet interventions · 2026Article
- Internet-delivered unguided psychodynamic vs. cognitive behavior therapy for anxiety and depression symptoms: A large, full factorial randomized controlled trial on treatment length and peer support.Internet interventions · 2026Article
- The Impact of Emergency Department Process Optimization Combined With Health Education on the Treatment Outcomes and Anxiety and Depression in Patients With Acute Ischemic Stroke.Actas espanolas de psiquiatria · 2026Article
- Guided versus unguided internet-administered emotional awareness and expression therapy (I-EAET) for patients with persistent physical symptoms: A randomized trial.Internet interventions · 2026Article
- Service Urgency for Children and Youth: The Development of an Algorithm to Identify Urgent and Emergent Service Users in Children's Mental Health.International journal of environmental research and public health · 2026Article
- Article
- Personalized PHQ-9 test length using probability density estimation based on conditional probability and K-Nearest Neighbours.Internet interventions · 2026Article
- The end of "logging in": The next 10 years of internet interventions.Internet interventions · 2026Article
- Twelve-month outcomes and comparative costs of internet-delivered psychodynamic therapy versus cognitive-behavioral therapy for adolescent depression: a randomized controlled trial.Frontiers in psychiatry · 2026Article
- Beyond depressive symptoms: conceptualizing social suffering among displaced Syrians in Lebanon.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Patient Health Questionnaire-9 (PHQ-9) is a widely used tool for assessing depressive symptom severity and as a screening tool in the diagnosis of major depression. Designed as both a diagnostic instrument and a severity index, it is commonly used in primary care and research. However, findings regarding its reliability and validity for these dual purposes have been mixed. This study aimed to review the history of the PHQ-9, evaluate its factorial validity, and temporal measurement invariance using the dynamic fit index cutoffs framework for model fit evaluations. In a clinical sample of 3384 participants, strong correlations were found between items 1 and 2 (i.e., anhedonia and feeling depressed), indicating a substantial overlap in their coverage. Although a unidimensional factor structure was obtained, the model fit was suboptimal when contrasted with the sample dependent dynamic fit indices. Furthermore, measurement invariance between different treatment groups could not be established, strongly indicating that not all respondents use the PHQ-9 in the same manner as the only differentiating factor between groups was their randomized treatment group allocation. Moreover, temporal measurement invariance could not be convincingly established, in turn raising concerns about its comparability across time points. This suggests that observed changes in PHQ-9 scores over treatment weeks may, at least partly, reflect shifts in how participants engage with the scale rather than true changes in depressive symptomatology. In conclusion, our results raise questions about the validity of using the PHQ-9 to index depressive symptom severity and to monitor treatment outcomes over time.
Indexed as
Identifiers
40900414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.